Study Highlights Autoimmune, CTD Issues In Women Who Had Breast Implants
Executive Summary
Early results of a new study of 300 women who previously had breast implants, and a review of longer-term follow-up of patients who had their implants removed, found more patients have suffered autoimmune issues and connective tissue disease than have come out in FDA-mandated studies, according to the National Center for Health Research. NCHR was critical of FDA's and industry's approach to post-market surveillance of breast implants.
You may also be interested in...
FDA AdComm Will Address Breast Implant Risks, Benefits At March Meeting
US FDA’s General and Plastic Surgery Devices advisory panel will meet for two days in March to explore the risks and benefits of both silicone gel-filled and saline-filled breast implants.
FDA Looks To Lead World In Post-Market Device Surveillance With Safety Plan, Investments
US FDA Nov. 20 announced plans for a broad series of updates to its Medical Device Safety Action Plan for the next several months, with the goal that FDA "is consistently first among the world’s regulatory agencies to identify and act upon safety signals related to medical devices.
FDA Disputes Study On Breast Implant Safety
US FDA has taken the rare step of publicly disputing a study that seemed to show elevated risks of long-term adverse events associated with silicone breast implants.